The acronym GLP-1 has become an increasingly popular term in the health arena, especially in the context of weight loss.

After selling off a portion of its diabetes care business last year, Ypsomed is now fully exiting the diabetes care business ...

A new GLP-1 drug, orforglipron, comes in pill form and appears to be roughly as effective as injected drugs like Ozempic.

A Monell Chemical Senses Center study published this week in the Journal of Clinical Investigation offers renewed hope for ...

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

Medications like Ozempic and Zepbound work to mimic GLP-1, a hormone that makes you feel full. But there are also ways to ...

Doctors believe that GLP-1 agonists work by binding to receptors ... "Of course, one caveat is that we do not know the effects of this newer therapy on cardiovascular outcomes but this will ...

COYA 303 is an investigational biologic combination of COYA 301, Coya’s low-dose interleukin 2 (LD IL-2) and a GLP-1 receptor agonist ... Therefore, a combination therapy approach that dampens ...

Lilly markets its dual GIP and GLP-1 receptor agonist ... but unlike orforglipron, Rybelsus therapy has restrictions on food and water intake. Lilly’s recent phase III ACHIEVE-1 success ...